Asia Pacific Vital Signs Monitoring Devices Market Forecast to 2030 - Regional Analysis - By Product and End User

The Asia Pacific vital signs monitoring devices market was valued at US$5.03 billion in 2022 and is expected to reach US$12.76 billion by 2030; it is estimated to grow at a CAGR of 12.3% from 2022 to 2030.

Rise in Need for Remote Patient Monitoring Fuels the Asia Pacific Vital Signs Monitoring Devices Market

The demand for vital signs monitoring devices surged exponentially during the COVID-19 pandemic. Moreover, there was a sudden increase in Medicare Advantage claims during the COVID-19 pandemic. Remote patient monitoring has replaced conventional methods of monitoring patients' vital signs. The popularity of digital health has led to a rise in home care services, creating tremendous demand for devices such as pulse oximeters, BP monitors, and thermometers in homecare settings. Home healthcare has led to enhanced efficiency and cost-effectiveness in healthcare systems worldwide in the last few years. Similarly, the demand for remote patient monitoring increases with the growing preference for home care settings for the geriatric population and for people with critical conditions who require monitoring post-hospital care.

Advancements such as wireless technologies and wearable devices have improved interoperability among healthcare professionals and scalability among patients. These devices have made it easy to monitor heart conditions, weight gain/loss, blood pressure, sleep apnea, asthma, and chronic obstructive pulmonary disease. In addition, the requirement for remote vital signs monitoring devices grew during the COVID-19 crisis owing to a shift in consumer preference toward telehealth. The use of telehealth resulted in a significant decrease in the frequency of hospital visits and optimized the use of healthcare resources, making healthcare more sustainable. Additionally, people in rural and urban areas are becoming highly aware of telehealth services due to the influence of social media and favorable initiatives by healthcare facilities.

Asia Pacific Vital Signs Monitoring Devices Market Overview

The Asia Pacific vital signs monitoring devices market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth is highly attributed to the increasing awareness of chronic disorders and growing emphasis on preventive care with the help of advanced monitoring devices. In addition, the growing medical device industry in countries such as China, India, and Japan is leading to rapid market growth. In November 2022, Roche introduced a new digital diabetes management platform to provide patients with professional and easier diabetes management solutions. In February 2020, JD.com, one of the significant players in the Chinese retail market, launched a smart body temperature monitor to boost patient monitoring during the COVID-19 outbreak. Also, there are increasing incidences of infectious diseases in China, and as the country is the epicenter of the COVID-19 pandemic, the demand for vital signs monitoring devices is much higher. Thus, the above-mentioned factors fuel the vital signs monitoring devices market growth in China.

Asia Pacific Vital Signs Monitoring Devices Market Segmentation

The Asia Pacific vital signs monitoring devices market is segmented based on product, end user, and country.

Based on product, the Asia Pacific vital signs monitoring devices market is segmented into pulse oximeters, blood pressure monitors, temperature monitoring devices, and glucose monitors devices. The glucose monitors devices segment held the largest share in 2022. The glucose monitoring devices segment is further bifurcated into self glucose monitors and continuous glucose monitors. Additionally, the pulse oximeters segment is subsegmented into handheld pulse oximeters, table-top pulse oximeters, and pulse oximeter accessories. The temperature monitoring devices segment into digital thermometers, infrared thermometers, mercury filled thermometers, and liquid crystal thermometers. Further, by blood pressure monitoring devices, the market is categorized into digital blood pressure monitors, analog blood pressure monitors, ambulatory blood pressure monitors, mercury blood pressure monitors, and blood pressure instrument accessories.

By end user, the Asia Pacific vital signs monitoring devices market is segmented into hospitals & clinics, ambulatory care centers, home healthcare, and other. The hospitals & clinics segment held the largest share in 2022.

Based on country, the Asia Pacific vital signs monitoring devices market is categorized into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific vital signs monitoring devices market in 2022.

Koninklijke Philip NV, Medtronic Plc, Nihon Kohden, GE HealthCare Technologies Inc, OMRON Corp, Suntech Medical Inc, Masimo Corp, Contec Medical Systems Co Ltd, and Baxter Intonational Inc are some of the leading companies operating in the Asia Pacific vital signs monitoring devices market.